Analysis of the Economic-Financial Efficiency of Gout Treatment in Elderly Patients with Comorbidities in the Republic of Moldova
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
162 0
SM ISO690:2012
ROTARU, Larisa, GROPPA, Liliana, RUSSU, Eugen, KAZAK, Viktor, AGACHI, Svetlana, CODREANU, Cătălin O., SPINEI, Larisa, ARNAUT, Oleg, SÂRBU, Oxana, CORNEA, Cornelia. Analysis of the Economic-Financial Efficiency of Gout Treatment in Elderly Patients with Comorbidities in the Republic of Moldova. In: Mediterranean Journal of Rheumatology, 2023, vol. 34, pp. 327-331. ISSN 2459-3516. DOI: https://doi.org/10.31138/mjr.20230725.ao
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Mediterranean Journal of Rheumatology
Volumul 34 / 2023 / ISSN 2459-3516 /ISSNe 2529-198X

Analysis of the Economic-Financial Efficiency of Gout Treatment in Elderly Patients with Comorbidities in the Republic of Moldova

DOI:https://doi.org/10.31138/mjr.20230725.ao

Pag. 327-331

Rotaru Larisa12, Groppa Liliana12, Russu Eugen1, Kazak Viktor1, Agachi Svetlana1, Codreanu Cătălin O.3, Spinei Larisa1, Arnaut Oleg1, Sârbu Oxana1, Cornea Cornelia1
 
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
2 Timofei Moșneaga Republican Clinical Hospital,
3 University of Medicine and Pharmacy “Carol Davilla”, Bucharest
 
 
Disponibil în IBN: 24 octombrie 2023


Rezumat

Introduction: The costs of treating an elderly patient with gout are largely related to the treatment of concomitant pathological conditions and complications. Determining the costs of treating the disease is made by clinical and economic analysis, the task of which is to calculate the “cost of the illness”. Material and methods: A descriptive, selective study of 237 patients with gout. In order to study the clinical characteristics of gout in the elderly, all those included in the study was divided according to age at the time of examination: group I made up of patients with gout up to and including 59 years n=91, average age 48.1±7.4 years (from 30 years to 59 years), group II – over the age of 60 years inclusive n=146, average age 69.2±6.0 years, (60-86 years, p[removed]

Cuvinte-cheie
comorbidity, gout, Statistics